Great West Life Assurance CO Amicus Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 85,104 shares of FOLD stock, worth $909,761. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,104
Previous 100,538
15.35%
Holding current value
$909,761
Previous $1.18 Million
28.74%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding FOLD
# of Institutions
288Shares Held
321MCall Options Held
260KPut Options Held
261K-
Vanguard Group Inc Valley Forge, PA28.6MShares$306 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$300 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$293 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$261 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$226 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $3B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...